Primary Site >> Liver Cancer

Gene >> MECOM

Journal: Methods Mol Biol. 2012;891:341-70.
Title: Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Author: Themis, Michael
PMID: 22648780
Journal: Cancer Sci. 2015 Jul;106(7):929-37.
Title: EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-beta-mediated growth inhibition in hepatocellular carcinoma.
Author: Yasui, Kohichiroh|Konishi, Chika|Gen, Yasuyuki|Endo, Mio|Dohi, Osamu|Tomie, Akira|Kitaichi, Tomoko|Yamada, Nobuhisa|Iwai, Naoto|Nishikawa, Taichiro|Yamaguchi, Kanji|Moriguchi, Michihisa|Sumida, Yoshio|Mitsuyoshi, Hironori|Tanaka, Shinji|Arii, Shigeki|Itoh
PMID: 25959919
Journal: Oncotarget. 2016 Apr 19;7(16):21887-99.
Title: EVI1 promotes cell proliferation in HBx-induced hepatocarcinogenesis as a critical transcription factor regulating lncRNAs.
Author: Huang, Jin-Feng|Wang, Yue|Liu, Feng|Liu, Yin|Zhao, Chen-Xi|Guo, Ying-Jun|Sun, Shu-Han
PMID: 26967394
Journal: World J Gastroenterol. 2017 Nov 28;23(44):7818-7829.
Title: Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
Author: Yu, Ming-Chin|Lee, Chao-Wei|Lee, Yun-Shien|Lian, Jang-Hau|Tsai, Chia-Lung|Liu, Yi-Ping|Wu, Chun-Hsing|Tsai, Chi-Neu
PMID: 29209123